In addition, GLP-1 Ras’s beneficial role in patients with T2DM and high risk for CVD, including its anti-atherosclerotic effect, may also play a part in preventing severe forms of COVID-19, but more evidence is needed [14,45,52]. The gene discussed is GLP1R; the disease is COVID-19.